Document is current
Any future updates will be listed below
-
Authors
Kalkavan, Halime http://orcid.org/0000-0002-0090-4080
Rühl, Sebastian
Shaw, Jeremy J. P. http://orcid.org/0000-0002-7458-215X
Green, Douglas R. http://orcid.org/0000-0002-7332-1417
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 CA231620)
American Lebanese Syrian Associated Charities
Deutsche Forschungsgemeinschaft (KA 4830/1-1)
Bundesministerium für Bildung und Forschung (01EO2104)
Advanced Clinician Scientist Programm UMEA²
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA272387)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PB_194393)
- License Information
-
More Information
Article History
Received: 21 September 2022
Accepted: 27 April 2023
First Online: 5 June 2023
Competing interests
: D.R.G. consults for Ventus Therapeutics, Sonata Therapeutics and Horizon Therapeutics. The other authors declare no competing interests.
